Expert Talk
Nanotechnology in Pharmaceutics and Drug Delivery Systems
Nucleic acid pharmaceuticals have proven their potential to successfully treat or prevent intractable diseases
CDMOs
Choose your partner wisely!
Over the past decade the role of a contract development and manufacturing organisation CDMO in the biotech and pharma industries
Reimagining Drug Development
How emerging technologies can accelerate cancer breakthroughs
In her book Sudden Death Rita Mae Brown defined insanity as doing the same things over and over
Innovations in Drug Delivery Systems for Respiratory Diseases
Challenges and future directions
Conventional drug delivery systems for respiratory diseases such as inhalers and nebulizers often face challenges
Cell Therapies
THE FUTURE IS NOW
Cost and disease target identification The current cost associated with manufacturing cell therapies is very high
Global Clinical Trials
Global clinical trials have undergone significant evolution over the past decade primarily influenced by advancements
miRNAs
The Tiny Molecules Revolutionising Diagnostics in Heart Disease and Cancer
MiRNAs are gaining prominence in cancer diagnostics due to their pivotal role in regulating gene expression
Comprehensive Assessment of Risk-based Quality Management Adoption in Clinical Trials
Many companies have implemented some components of RBQM in some trials but full implementation of RBQM across
Asia-Pacific Trials
The AsiaPacific APAC region is becoming increasingly influential in the global clinical trials landscape due to several key trends
Unlocking the Potential of Hydrophobic Ion Pairing in Pharmaceutical Formulations
Hydrophobic ion pairing HIP represents a promising avenue within pharmaceutical science offering a solution to the challenges
